9:22 AM
Leo Group India
| ||
| Shanghai Pharmaceuticals to market Aerocrine's instrument NIOX MINO and test ... pharmabiz.com SPH is China's third largest pharmaceutical company with more than 37,000 employees and an annual turnover exceeding 54 billion RMB (approximately 55 billion SEK or US$ 8.5 billion). The company, which is partly state owned, manufactures and markets ... See all stories on this topic » | ||
| NovaBay Pharmaceuticals (NBY) Receives $2.6 Million From Partner Galderma Stockhouse 26, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary ... See all stories on this topic » | ||
| Major Pharmaceutical Stocks Rise After Moody's Upgrades Industry to "Stable" Stockhouse NEW YORK, NY -- (Marketwire) -- 09/26/12 -- The Pharmaceutical Industry has faced significant headwinds in 2012 as patent cliffs and the emergence of generic drug makers have threatened billions in revenue for top selling drugs. Pharmaceutical stocks ... See all stories on this topic » | ||
| Rexahn Pharmaceuticals Granted European Patent for Novel Anti-cancer ... DailyFinance ROCKVILLE, Md.--(BUSINESS WIRE)-- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office ... See all stories on this topic » | ||
| NPPA refuses to hike prices of imported insulins, eye drops Business Standard The drug price regulator National Pharmaceutical Pricing Authority (NPPA) has refused to allow multinational pharmaceutical companies to hike prices of imported insulins sold in the country. In a recent authority meeting, NPPA rejected all applications ... See all stories on this topic » | ||
| Will Stem Cell Research Lift Pharmaceutical Stock Values? Seeking Alpha It was the year 1998 that human embryonic stem cells were first identified. Just nine years after that, a group of scientists in Japan were able to take skin cells and reprogram them with very powerful viruses to create an induced pluripotent stem cell ... See all stories on this topic » | ||
| Alnylam wins infringement case vs. Canadian firm Boston Herald In the suit filed in January, Cambridge-based Alnylam alleged Tekmira improperly provided lipid nanoparticle-formulated small interfering RNA molecules to pharmaceutical collaborators, infringing on several patents exclusively licensed to Alnylam. See all stories on this topic » | ||
| United States : McKesson Announces New President of US Pharmaceutical ... Equities.com McKesson Corporation today announced that Mark Walchirk has been named president, McKesson U.S. Pharmaceutical, effective immediately. Walchirk, who was most recently chief operating officer of McKesson Specialty Health, has held numerous ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment